InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the full record of transactions filed by Shah Nimish P. Director active across 1 company, notably Apogee Therapeutics, Inc.. Cumulatively, 2 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €26.5m. History available since 13 July 2023. The latest transaction was filed on 3 September 2026 (Disposition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条